In the spotlight: Navigating the evolving landscape of hormone therapy for menopause
American Journal of Health-System Pharmacy · 04.11.2026
DOI: 10.1093/ajhp/zxag362 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 04.11.2026. Verfasst von Erin Carson und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Illinois Chicago Retzky College of Pharmacy, Rockford, IL, USA. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
On November 10, 2025, the Food and Drug Administration (FDA) announced their intention to remove the boxed warnings associated with hormone therapy (HT).1 This announcement follows a July 2025 expert panel, a public comment period, and a Health and Human Services–driven drug utilization analysis. It also follows decades of controversy surrounding the safety, efficacy, and prescribing practices of HT, formerly known as hormone replacement therapy or HRT, for menopause-related conditions. As a result of this announcement, 29 drug companies have submitted proposed labeling changes, with changes for 6 labels approved at the time of this publication.2 Removing the boxed warnings, formerly known as black box warnings, associated with HT represents a meaningful shift toward more nuanced, patient-specific clinical decision-making rather than broad, population-level risk assumptions. This change recognizes the many factors that may be taken into account when considering the risk-benefit ratio of HT for individual patients. Ultimately, these changes support more personalized HT decision-making and improve individualized patient care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Illinois Chicago Retzky College of Pharmacy, Rockford, IL, USA.
- The University of Georgia College of Pharmacy, Athens, GA, USA.
Zitieren
APA
Carson, E., & Stone, R. H. (2026). In the spotlight: Navigating the evolving landscape of hormone therapy for menopause. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag362
Vancouver
Carson E, Stone RH. In the spotlight: Navigating the evolving landscape of hormone therapy for menopause. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxag362
BibTeX
@article{Carson2026,
author = {Carson, Erin and Stone, Rebecca H},
title = {In the spotlight: Navigating the evolving landscape of hormone therapy for menopause},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
doi = {10.1093/ajhp/zxag362}
}
EUVIMED